support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulleted grid_view

12/01/2022

Change in the Management of CHEPLAPHARM
Archive
Read more chevron_right

11/29/2022

CHEPLAPHARM remains on growth track
Archive
Read more chevron_right

10/25/2022

CHEPLAPHARM receives growth capital of €550 Million from two leading global investors
Archive
Read more chevron_right

08/29/2022

CHEPLAPHARM increases revenue and earnings in the first half of 2022
Archive
Read more chevron_right

06/01/2022

CHEPLAPHARM strengthens its oncology portfolio
Archive
Read more chevron_right

05/16/2022

CHEPLAPHARM acquires rights to CMV medicine
Archive
Read more chevron_right

04/29/2022

CHEPLAPHARM continues profitable growth track in 2021 as well
Archive
Read more chevron_right

03/21/2022

Significant and sustainable site expansion
Archive
Read more chevron_right

03/01/2022

CHEPLAPHARM acquires additional oncology drugs
Archive
Read more chevron_right

Back

Back to top expand_less